ADIPOQ and metabolic syndrome: While low serum adiponectin levels have been associated with central obesity, insulin resistance, metabolic syndrome, and type 2 diabetes, ADIPOQ (rs16861209) has been significantly associated with elevated fasting serum adiponectin levels [37,38].